[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fq8Yy9Vejm7AntGZ2-HiP0bbQmAlQH3vKj56RkYrvHhY":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":37,"phaseBuckets":43,"rows":50},"Florida State University",[4],231,false,52,1,34108,4,228,[14,17,20,23,26,28,31,34],{"name":15,"count":16},"Obesity",17,{"name":18,"count":19},"Pain",13,{"name":21,"count":22},"Hypertension",11,{"name":24,"count":25},"Anxiety",10,{"name":27,"count":25},"Chronic Pain",{"name":29,"count":30},"Healthy",9,{"name":32,"count":33},"Social Anxiety Disorder",7,{"name":35,"count":36},"HIV Infections",6,[38],{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT06430580","Cannabinoids and Biological Reactivity to Stress","2026-09-30","Hydrocortisone",[44,45,46,47,48,49],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[51,77,95,113,131,156],{"intervention":42,"totalTrials":9,"cells":52},{"EARLY_PHASE1":53,"PHASE1":66,"PHASE2":69,"PHASE3":71,"PHASE4":73,"NA":75},{"trials":54,"activeCount":9,"soonestReadout":41},[55],{"nctId":39,"briefTitle":40,"status":56,"phases":57,"primaryCompletion":41,"completion":41,"start":58,"enrollment":59,"conditions":60,"interventions":62},"RECRUITING",[44],"2024-09-30",36,[61],"Cannabis Use Disorder",[42,63,64,65],"Yohimbine Hydrochloride","Cornstarch Placebo 20mg","Cornstarch Placebo 54mg",{"trials":67,"activeCount":68},[],0,{"trials":70,"activeCount":68},[],{"trials":72,"activeCount":68},[],{"trials":74,"activeCount":68},[],{"trials":76,"activeCount":68},[],{"intervention":63,"totalTrials":9,"cells":78},{"EARLY_PHASE1":79,"PHASE1":85,"PHASE2":87,"PHASE3":89,"PHASE4":91,"NA":93},{"trials":80,"activeCount":9,"soonestReadout":41},[81],{"nctId":39,"briefTitle":40,"status":56,"phases":82,"primaryCompletion":41,"completion":41,"start":58,"enrollment":59,"conditions":83,"interventions":84},[44],[61],[42,63,64,65],{"trials":86,"activeCount":68},[],{"trials":88,"activeCount":68},[],{"trials":90,"activeCount":68},[],{"trials":92,"activeCount":68},[],{"trials":94,"activeCount":68},[],{"intervention":64,"totalTrials":9,"cells":96},{"EARLY_PHASE1":97,"PHASE1":103,"PHASE2":105,"PHASE3":107,"PHASE4":109,"NA":111},{"trials":98,"activeCount":9,"soonestReadout":41},[99],{"nctId":39,"briefTitle":40,"status":56,"phases":100,"primaryCompletion":41,"completion":41,"start":58,"enrollment":59,"conditions":101,"interventions":102},[44],[61],[42,63,64,65],{"trials":104,"activeCount":68},[],{"trials":106,"activeCount":68},[],{"trials":108,"activeCount":68},[],{"trials":110,"activeCount":68},[],{"trials":112,"activeCount":68},[],{"intervention":65,"totalTrials":9,"cells":114},{"EARLY_PHASE1":115,"PHASE1":121,"PHASE2":123,"PHASE3":125,"PHASE4":127,"NA":129},{"trials":116,"activeCount":9,"soonestReadout":41},[117],{"nctId":39,"briefTitle":40,"status":56,"phases":118,"primaryCompletion":41,"completion":41,"start":58,"enrollment":59,"conditions":119,"interventions":120},[44],[61],[42,63,64,65],{"trials":122,"activeCount":68},[],{"trials":124,"activeCount":68},[],{"trials":126,"activeCount":68},[],{"trials":128,"activeCount":68},[],{"trials":130,"activeCount":68},[],{"intervention":132,"totalTrials":9,"cells":133},"Creatine monohydrate",{"EARLY_PHASE1":134,"PHASE1":136,"PHASE2":138,"PHASE3":150,"PHASE4":152,"NA":154},{"trials":135,"activeCount":68},[],{"trials":137,"activeCount":68},[],{"trials":139,"activeCount":68},[140],{"nctId":141,"briefTitle":142,"status":143,"phases":144,"primaryCompletion":145,"completion":145,"start":146,"enrollment":19,"conditions":147,"interventions":149},"NCT04471792","Creatine Use and Muscle Stretching in Peripheral Artery Disease","COMPLETED",[46],"2022-12-15","2020-05-12",[148],"Peripheral Arterial Disease",[132],{"trials":151,"activeCount":68},[],{"trials":153,"activeCount":68},[],{"trials":155,"activeCount":68},[],{"intervention":157,"totalTrials":9,"cells":158},"Caffeine",{"EARLY_PHASE1":159,"PHASE1":161,"PHASE2":163,"PHASE3":165,"PHASE4":167,"NA":169},{"trials":160,"activeCount":68},[],{"trials":162,"activeCount":68},[],{"trials":164,"activeCount":68},[],{"trials":166,"activeCount":68},[],{"trials":168,"activeCount":68},[],{"trials":170,"activeCount":68},[171],{"nctId":172,"briefTitle":173,"status":143,"phases":174,"primaryCompletion":175,"completion":175,"start":176,"enrollment":177,"conditions":178,"interventions":179},"NCT02214290","Effect of Oral Caffeine and L-Citrulline Supplementation on Arterial Function in Healthy Males",[49],"2014-03","2012-09",16,[21,29],[157]]